Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 125355
Published online Oct 15, 2026. doi: 10.4239/wjd.125355
Published online Oct 15, 2026. doi: 10.4239/wjd.125355
Table 5 Comparison of baseline clinical characteristics stratified by gender, n (%)/mean ± SD
| Variables | Male | Female | ||||
| Non-MASLD | MASLD (n = 169) | P value | Non-MASLD | MASLD (n = 99) | P value | |
| Age (year) | 58.59 ± 12.31 | 49.11 ± 12.97 | < 0.001 | 63.15 ± 10.65 | 57.63 ± 11.93 | < 0.001 |
| Duration (year) | 6.00 (2.25, 15.00) | 3.00 (1.00, 8.00) | < 0.001 | 10.00 (3.00, 17.00) | 4.00 (2.00, 10.00) | < 0.001 |
| SBP (mmHg) | 137.60 ± 18.35 | 139.93 ± 14.87 | 0.174 | 141.48 ± 20.46 | 140.39 ± 20.16 | 0.673 |
| DBP (mmHg) | 83.88 ± 12.12 | 87.84 ± 11.20 | 0.001 | 77.10 ± 10.70 | 82.54 ± 13.42 | < 0.001 |
| BMI (kg/m2) | 25.34 ± 3.86 | 28.67 ± 4.97 | < 0.001 | 24.85 ± 3.63 | 27.55 ± 4.55 | < 0.001 |
| WC (cm) | 95.80 ± 9.45 | 103.93 ± 11.79 | < 0.001 | 90.43 ± 12.28 | 95.59 ± 10.96 | < 0.001 |
| HC (cm) | 100.95 ± 8.14 | 107.25 ± 10.77 | < 0.001 | 98.63 ± 9.70 | 102.79 ± 11.10 | 0.001 |
| LDL-C (mmol/L) | 2.96 ± 0.90 | 3.16 ± 0.93 | 0.038 | 3.11 ± 0.95 | 3.23 ± 1.01 | 0.299 |
| HDL-C (mmol/L) | 1.19 ± 0.28 | 1.15 ± 0.31 | 0.200 | 1.33 ± 0.29 | 1.24 ± 0.29 | 0.016 |
| TG (mmol/L) | 2.03 ± 2.68 | 3.12 ± 3.60 | 0.001 | 1.56 ± 1.66 | 2.09 ± 1.43 | 0.008 |
| TC (mmol/L) | 4.72 ± 1.28 | 5.18 ± 1.53 | 0.002 | 4.90 ± 1.31 | 5.15 ± 1.40 | 0.143 |
| ALT (U/L) | 20.00 (15.00, 27.00) | 29.00 (21.00, 46.00) | < 0.001 | 18.00 (13.00, 29.00) | 28.00 (18.50, 42.00) | < 0.001 |
| AST (U/L) | 17.00 (14.00, 21.00) | 22.00 (17.00, 32.00) | < 0.001 | 18.00 (14.00, 23.00) | 22.00 (16.00, 36.50) | < 0.001 |
| FBG (mmol/L) | 9.15 ± 3.33 | 9.92 ± 3.29 | 0.025 | 9.14 ± 3.73 | 9.28 ± 2.73 | 0.737 |
| HbA1c (%) | 8.60 ± 2.29 | 8.75 ± 1.86 | 0.488 | 8.55 ± 2.02 | 8.68 ± 1.95 | 0.605 |
| BUN (mmol/L) | 6.17 ± 2.17 | 5.69 ± 3.41 | 0.104 | 5.31 ± 1.87 | 5.33 ± 1.56 | 0.912 |
| UA (mmol/L) | 350.02 ± 97.94 | 386.92 ± 104.17 | < 0.001 | 296.78 ± 84.93 | 325.13 ± 97.32 | 0.013 |
| Scr (mmol/L) | 71.85 ± 25.51 | 67.20 ± 13.64 | 0.033 | 58.05 ± 22.45 | 58.41 ± 32.85 | 0.913 |
| Hcy (μmol/L) | 14.96 ± 6.32 | 16.03 ± 8.10 | 0.153 | 12.30 ± 5.82 | 12.61 ± 9.22 | 0.737 |
| RBC (× 1012/L) | 4.80 ± 0.56 | 4.98 ± 0.51 | 0.001 | 4.28 ± 0.50 | 4.51 ± 0.40 | < 0.001 |
| Hb (g/L) | 147.66 ± 16.79 | 154.50 ± 16.42 | < 0.001 | 128.18 ± 16.78 | 134.32 ± 13.88 | 0.002 |
| WBC (× 109/L) | 6.05 ± 1.63 | 6.57 ± 2.11 | 0.007 | 5.91 ± 1.77 | 6.39 ± 1.93 | 0.037 |
| PLT (× 109/L) | 207.93 ± 54.88 | 229.49 ± 59.17 | < 0.001 | 230.16 ± 60.66 | 240.97 ± 63.53 | 0.165 |
| Smoking | - | - | 0.782 | - | - | 1.000 |
| No | 109 (52.91) | 87 (51.48) | - | 171 (98.28) | 98 (98.99) | - |
| Yes | 97 (47.09) | 82 (48.52) | - | 3 (1.72) | 1 (1.01) | - |
| HT | - | - | 0.015 | - | - | 0.721 |
| No | 100 (48.54) | 61 (36.09) | - | 83 (47.70) | 45 (45.45) | - |
| Yes | 106 (51.46) | 108 (63.91) | - | 91 (52.30) | 54 (54.55) | - |
| eGDR quantile | - | - | < 0.001 | - | - | 0.412 |
| Q1 | 31 (15.05) | 63 (37.28) | - | 38 (21.84) | 30 (30.30) | - |
| Q2 | 55 (26.70) | 38 (22.49) | - | 43 (24.71) | 25 (25.25) | - |
| Q3 | 54 (26.21) | 40 (23.67) | - | 45 (25.86) | 22 (22.22) | - |
| Q4 | 66 (32.04) | 28 (16.57) | - | 48 (27.59) | 22 (22.22) | - |
- Citation: Yin JT, Lu YX, Li ZM, Niu S. Association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients. World J Diabetes 2026; 17(10): 125355
- URL: https://www.wjgnet.com/1948-9358/full/v17/i10/125355.htm
- DOI: https://dx.doi.org/10.4239/wjd.125355